share_log

Nurix Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1 Clinical Trial Cancer Data for BTK Degrader NX-5948.

Nurix Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1 Clinical Trial Cancer Data for BTK Degrader NX-5948.

nurix therapeutics的股票在公司宣布将展示其BTk降解剂NX-5948的I期临床试验癌症数据后上涨。
Benzinga ·  2024/12/02 21:43

Nurix Therapeutics Shares Are Trading Higher After the Company Announced It Will Present Its Phase 1 Clinical Trial Cancer Data for BTK Degrader NX-5948.

nurix therapeutics的股票在公司宣布将展示其BTk降解剂NX-5948的第一阶段临床试验癌症数据后上涨。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发